We've Rebranded!

HT-ADME is now NE-ADME (New Era of ADME & Beyond) Conference

Thursday, June 16th, 2022

In-Person Event - Novartis Institutes for BioMedical Research, Cambridge, MA

NE-ADME event will be an in-person meeting. However, remote attendance option will also be made available just in case you are still not able to travel.

Download NE-ADME 2022 Program Guide Here!

Plenary Speakers for 2022


Brooke M. Rock, PhD

Director, Department of Pharmacokinetics & Drug Metabolism @ Amgen Inc.

How Understanding ADME Properties of Multispecific Biologics Can Increase Speed to the Clinic


Roger D. Kamm, PhD

Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering @ MIT

Vascular and Lymphatic Barrier Function in the Brain and Subcutaneous Compartments


Speakers Confirmed for 2022


Mailys De Sousa Mendes, PhD

Senior Research Scientist @ Certara UK

Mechanistic Modeling of Caco-2 Experiments to Estimate Intrinsic Permeability


Li Di, PhD

Research Fellow @ Pfizer, Inc.

Prediction Accuracy of Volume of Distribution Using In Vitro, In Vivo, PBPK and QSAR Methods


Charles Knutson, PhD

Associate Director @ Novartis Institutes for BioMedical Research

Panel Discussion


James Kozloski, PhD

Principal Research Scientist @ IBM

Populations of Models for Virtual Patient/Cohort Construction in ADME/PK


Ryan Pelis, PhD

Senior Investigator I @ Novartis Institutes for BioMedical Research

Tools Toward Predicting Oral Lymphatic Absorption


Haojing Rong, PhD

Vice President of Preclinical Development @ Kymera Therapeutics

The Knowns and Unknowns of ADME/PK of Targeted Protein Degraders


Yuanxin Xu, PhD

Sr. VP of Early Development and Translational Medicine @ Intellia Therapeutics, Inc.

Of Mice and Man: Path to Clinical CRISPR/Cas9 Genome Editing Therapeutic Development



Doug Burdette, PhD

Director of DMPK and Clinical Pharmacology @ Moderna Therapeutics, Inc.

Assessment of Amino Lipid Biodistribution, Metabolism, and Elimination in Rats after LNP IV Administration to Understand In Vivo Fate and Potential for DDI


Dipen Vyas, PhD

Study Director (ADME-Tox) @ BioIVT

Long-term HEPATOPAC® Cultures: Model Validation for ADME-Tox Applications


Panel Discussion:

Expedited Drug Discovery Post-COVID 


Brooke Rock, Amgen

Doug Burdette, Moderna

Li Di, Pfizer

Charlie Knutson, Novartis

SESSION I: Advances in ADME of New Modalities

SESSION II: Novel In Silico Tools for ADME in Drug Discovery

SESSION III: Contributions of Vascular and Lymphatic Compartments to Drug Absorption

SESSION IV: ADME of COVID Therapeutics and Beyond


Session I: Advances in ADME of New Modalities

Session II: Novel in silico Tools for ADME in Drug Discovery

Session III: Drug Delivery to Unusual Targets

Session IV: ADME of COVID Therapeutics and Beyond



Click here to register for the NE-ADME conference online.

NE-ADME 2022 will take place June 16, 2022

Novartis, Cambridge, MA


The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3


Sign Up Today!

Privacy Policy